Literature DB >> 1483506

Cell death in the rat retina after a pressure-induced ischaemia-reperfusion insult: an electron microscopic study. I. Ganglion cell layer and inner nuclear layer.

E R Büchi1.   

Abstract

In rats, a pressure-induced ischaemia-reperfusion insult can lead to retinal cell death. In order to elucidate the underlying mechanisms, we performed a qualitative study of the ultrastructural morphology of degenerating retinal cells in the ganglion cell and inner nuclear layers at several time points after the insult. Three morphologically distinct types of cell death could be individualized. Type I was characterized by progressive karyo- and cytolysis and was consistent with necrosis. Type II exhibited progressive shrinkage and condensation of the nuclear and cytoplasmic components followed by heterophagic elimination, thus resembling apoptosis. Type III was characterized mainly by homogenization of the nucleoplasm and cytoplasm and dilation of the perinuclear cisternae and endoplasmic reticulum, thus showing features of 'non-lysosomal vesiculate' cell death. This study lends support to the concept that there may exist a fair but limited number of types of cell death in the retina.

Entities:  

Mesh:

Year:  1992        PMID: 1483506     DOI: 10.1016/s0014-4835(05)80173-3

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  45 in total

1.  Delayed axonal degeneration in slow Wallerian degeneration mutant mice detected using diffusion tensor imaging.

Authors:  M Xie; Q Wang; T-H Wu; S-K Song; S-W Sun
Journal:  Neuroscience       Date:  2011-09-25       Impact factor: 3.590

2.  Opioid receptor activation: suppression of ischemia/reperfusion-induced production of TNF-α in the retina.

Authors:  Shahid Husain; Gregory I Liou; Craig E Crosson
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-20       Impact factor: 4.799

3.  High intraocular pressure-induced ischemia and reperfusion injury in the optic nerve and retina in rats.

Authors:  M Adachi; K Takahashi; M Nishikawa; H Miki; M Uyama
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-07       Impact factor: 3.117

4.  Evaluation of corpus geniculatum laterale and vitreous fluid by magnetic resonance spectroscopy in patients with glaucoma; a preliminary study.

Authors:  S Doganay; C Cankaya; A Alkan
Journal:  Eye (Lond)       Date:  2012-05-25       Impact factor: 3.775

5.  Involvement of microRNA-181a and Bim in a rat model of retinal ischemia-reperfusion injury.

Authors:  Yu He; Jin-Nan Liu; Jun-Jun Zhang; Wei Fan
Journal:  Int J Ophthalmol       Date:  2016-01-18       Impact factor: 1.779

Review 6.  Human ganglion cells express the alpha-2 adrenergic receptor: relevance to neuroprotection.

Authors:  F B Kalapesi; M T Coroneo; M A Hill
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

7.  Y-27632, a Rho-associated protein kinase inhibitor, attenuates neuronal cell death after transient retinal ischemia.

Authors:  Akira Hirata; Masaru Inatani; Yasuya Inomata; Naoko Yonemura; Takahiro Kawaji; Megumi Honjo; Hidenobu Tanihara
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-08-31       Impact factor: 3.117

8.  Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin.

Authors:  A J Barber; E Lieth; S A Khin; D A Antonetti; A G Buchanan; T W Gardner
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

9.  Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury.

Authors:  Anna K Junk; Antonios Mammis; Sean I Savitz; Manjeet Singh; Steven Roth; Samit Malhotra; Pearl S Rosenbaum; Anthony Cerami; Michael Brines; Daniel M Rosenbaum
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-18       Impact factor: 11.205

10.  Retinal ischemia-induced apoptosis is associated with alteration in Bax and Bcl-x(L) expression rather than modifications in Bak and Bcl-2.

Authors:  Nathalie Produit-Zengaffinen; Constantin J Pournaras; Daniel F Schorderet
Journal:  Mol Vis       Date:  2009-10-19       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.